Coronary Stents Companies

Latest Coronary stents Companies Updates:

Boston Scientific Corporation (US) Launched their Promus Premier™ Plus DES featuring a redesigned delivery system for improved control and ease of stent placement.Entered into a strategic partnership with a Chinese medical device company to expand their market reach in Asia.

Abbott Laboratories (US) Received FDA approval for their Absorb™ BVS (bioresorbable vascular scaffold) in Europe, further diversifying their stent portfolio.Collaborated with research institutions to investigate the long-term clinical benefits of bioresorbable stents compared to traditional DES.

Biotronik SE & Co. (Germany) Developed their Orsiro™ Hybrid DES combining a durable metallic platform with a bioabsorbable polymer coating for optimal long-term results.Partnered with digital health startups to explore innovative tools for remote patient monitoring and post-PCI follow-up care.

Medtronic Plc (Ireland) Introduced their Resolute Onyx™ DES with a thinner strut design intended to improve vessel flexibility and minimize potential complications.Focused on expanding their offerings for complex coronary anatomies and bifurcation lesions through dedicated stent configurations.

The Society for Cardiovascular Angiography and Interventions (SCAI) Released updated guidelines on best practices for PCI procedures, emphasizing patient selection, stent selection, and optimal deployment techniques.Advocated for continued research and development in stent technology to address unmet clinical needs and improve patient outcomes.

List of Coronary stents Key companies in the market

• Abbott


• B Braun Melsungen AG


• Biotronik SE & Co. KG


• Boston Scientific Corporation


• C R Bard Inc.


• Cook Medical


• Elixir Medical Corporation


• Medtronic plc


• Meril Life Sciences


• Micro Port Scientific Corporation


• Stentys SA